178 related articles for article (PubMed ID: 3815349)
1. Acetylation phenotype in colorectal carcinoma.
Ilett KF; David BM; Detchon P; Castleden WM; Kwa R
Cancer Res; 1987 Mar; 47(5):1466-9. PubMed ID: 3815349
[TBL] [Abstract][Full Text] [Related]
2. Acetylation phenotype is not associated with breast cancer.
Ilett KF; Detchon P; Ingram DM; Castleden WM
Cancer Res; 1990 Oct; 50(20):6649-51. PubMed ID: 2208127
[TBL] [Abstract][Full Text] [Related]
3. Hepatic acetylator phenotype in bladder cancer patients.
Ladero JM; Kwok CK; Jara C; Fernandez L; Silmi AM; Tapia D; Uson AC
Ann Clin Res; 1985; 17(3):96-9. PubMed ID: 4051447
[TBL] [Abstract][Full Text] [Related]
4. N-acetylation phenotyping with sulfamethazine in an Iranian population.
Sardaş S; Lahijany B; Cok I; Karakaya AE
Pharmacogenetics; 1993 Jun; 3(3):131-4. PubMed ID: 8334437
[TBL] [Abstract][Full Text] [Related]
5. Polymorphic N-acetylation of sulfamethazine and benzidine by human liver: implication for cancer risk?
Peters JH; Gordon GR; Lin E; Green CE; Tyson CA
Anticancer Res; 1990; 10(1):225-9. PubMed ID: 2334132
[TBL] [Abstract][Full Text] [Related]
6. N-acetylation and oxidative capacity in aged volunteers determined with sulfamethazine and antipyrine.
Siegmund W; Franke G; Wulkow R; Hanke W; Thonack R
Int J Clin Pharmacol Ther Toxicol; 1991 Dec; 29(12):469-73. PubMed ID: 1813431
[TBL] [Abstract][Full Text] [Related]
7. [Acetylation phenotype in Graves' disease].
Górnik W; Syrenicz A; Gawrońska-Szklarz B; Wójcicki J
Pol Tyg Lek; 1989 Aug 7-14; 44(32-33):743-5. PubMed ID: 2641798
[TBL] [Abstract][Full Text] [Related]
8. Sulphamethoxazole acetylation in fast and slow acetylators.
Bozkurt A; Basci NE; Isimer A; Tuncer M; Erdal R; Kayaalp SO
Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):164-6. PubMed ID: 2338369
[TBL] [Abstract][Full Text] [Related]
9. Effect of physical training on sulfamethazine acetylation rate.
Abzalov RA; Nigmatullina RR; Khairullina GN; Garmonov SY; Shakirova LS; Evgen'ev MI
Bull Exp Biol Med; 2000 Dec; 130(12):1141-3. PubMed ID: 11276304
[TBL] [Abstract][Full Text] [Related]
10. Acetylator phenotyping in patients with malignant lymphomas, using caffeine as the metabolic probe.
William BM; Abdel-tawab AM; Hassan EA; Mohamed OF
Pol J Pharmacol; 2004; 56(4):445-9. PubMed ID: 15520499
[TBL] [Abstract][Full Text] [Related]
11. Genetically determined sparteine oxidation and sulfadimidine acetylation polymorphism in patients with non-occupational urinary bladder cancer.
Orzechowska-Juzwenko K; Niewiński P; Pawlik J; Milejski P; Dembowski J; Swiebodzki L; Lorenz J
Mater Med Pol; 1994; 26(4):145-8. PubMed ID: 7666680
[TBL] [Abstract][Full Text] [Related]
12. Acetylation phenotypes in patients with bladder carcinoma.
Bicho MP; Breitenfeld L; Carvalho AA; Manso CF
Ann Genet; 1988; 31(3):167-71. PubMed ID: 3265609
[TBL] [Abstract][Full Text] [Related]
13. [Phenotypes of oxidation and acetylation in Alzheimer's disease--preliminary report].
Milejski P; Orzechowska-Juzwenko K; Niewiński P; Hurkacz M; Czarnik-Matusewicz H; Leszek J; Rudzik J; Grotthus B
Psychiatr Pol; 2007; 41(2):261-9. PubMed ID: 17598435
[TBL] [Abstract][Full Text] [Related]
14. Inheritance of acetylator phenotype in mice.
Tannen RH; Weber WW
J Pharmacol Exp Ther; 1980 Jun; 213(3):480-4. PubMed ID: 6970808
[TBL] [Abstract][Full Text] [Related]
15. Incidence of isoniazid acetylation phenotypes in North Indians.
Gupta RC; Nair CR; Jindal SK; Malik SK
Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):259-64. PubMed ID: 6746149
[TBL] [Abstract][Full Text] [Related]
16. Acetylator polymorphism in human colorectal carcinoma.
Ladero JM; González JF; Benítez J; Vargas E; Fernández MJ; Baki W; Diaz-Rubio M
Cancer Res; 1991 Apr; 51(8):2098-100. PubMed ID: 2009528
[TBL] [Abstract][Full Text] [Related]
17. [Acetylation phenotype in patients with lung cancer].
Cofta S; Lowicki Z; Młynarczyk W
Pneumonol Alergol Pol; 1995; 63(7-8):407-9. PubMed ID: 8520558
[TBL] [Abstract][Full Text] [Related]
18. Comparison between serum and urinary sulphadimidine acetylation as predictors of isoniazid acetylator status in patients with pulmonary tuberculosis.
Singh SP; Pande JN; Khilnani GC; Kailash S
Indian J Chest Dis Allied Sci; 1996; 38(1):5-11. PubMed ID: 16892742
[TBL] [Abstract][Full Text] [Related]
19. [Biotransformation of phenazone and sulfadimidine as markers of liver metabolism of drug and xenobiotic oxidation and acetylation in women with breast cancer].
Orzechowska-Juzwenko K; Wiela-Hojeńska A; Milejski P; Cieślińska A; Hudziec P; Adamska M
Przegl Lek; 1997; 54(2):103-6. PubMed ID: 9198818
[TBL] [Abstract][Full Text] [Related]
20. [Phenotypic changes in acetylation in tumor patients].
Bulovskaia LN; Blinov NN; Simonov NN; Krupkin RG; Kolosov AI
Vopr Onkol; 1978; 24(10):76-9. PubMed ID: 716322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
